BPN endopump
Selected indexed studies
- Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial. (JAMA Intern Med, 2018) [PMID:29799968]
- Composición corporal de niños de entre 8 y 10 años de edad, con y sin antecedente de bajo peso al nacer, residentes en el estado de Querétaro, México. (Nutr Hosp, 2016) [PMID:27513486]
- Editorial: Motivations for physical activity. (Front Psychol, 2024) [PMID:38974105]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder: A Randomized Clinical Trial. (2018) pubmed
- Composición corporal de niños de entre 8 y 10 años de edad, con y sin antecedente de bajo peso al nacer, residentes en el estado de Querétaro, México. (2016) pubmed
- Editorial: Motivations for physical activity. (2024) pubmed
- Development of a novel peptide inhibitor of subtilisin BPN'. (2022) pubmed
- The GSM BPN-15606 as a Potential Candidate for Preventative Therapy in Alzheimer's Disease. (2020) pubmed
- Basic Psychological Needs and Subsequent Suicidal Thoughts in Real Time. (2026) pubmed
- BPN, a marine-derived PTP1B inhibitor, activates insulin signaling and improves insulin resistance in C2C12 myotubes. (2018) pubmed
- Durability of Biodegradable Polymer Nanocomposites. (2021) pubmed
- Synthesis and Biological Evaluation of New Fluorescent Probe BPN-01: A Model Molecule for Fluorescence Image-guided Surgery. (2023) pubmed
- Biodegradable Biopolymeric Nanoparticles for Biomedical Applications-Challenges and Future Outlook. (2023) pubmed